Overview

Vivek Ganapathy Ramaswamy is an American entrepreneur; author; and political figure who founded Roivant Sciences; a pharmaceutical company that acquires and develops shelved drug candidates from larger firms. Born to Indian immigrants in Cincinnati; Ramaswamy attended Harvard and Yale Law School before working at a hedge fund and then launching Roivant in 2014. The company's IPO in 2021 valued it at over $7 billion; though its business model drew criticism as financial engineering rather than genuine pharmaceutical innovation. Ramaswamy ran for the Republican presidential nomination in 2024; positioning himself as an anti-woke culture warrior and Trump ally; before dropping out and endorsing Trump. After Trump's election; Ramaswamy was appointed co-leader (alongside Elon Musk) of the Department of Government Efficiency (DOGE); a non-governmental advisory body tasked with identifying federal spending cuts and regulatory reform. DOGE drew intense controversy for its sweeping proposals to slash federal agencies; with critics arguing it lacked constitutional authority. Ramaswamy departed DOGE in February 2025 to pursue a gubernatorial campaign in Ohio.

Key Affiliations

Controversies & Concerns

Related Investigations (1)

Known Associates & Connections

Sources & Documentation

1 documented sources from official records, investigations, and reports